A5112367021- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Transcranial Magnetic Stimulation Studies
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
- Tryptophan and brain disorders
- EEG and Brain-Computer Interfaces
- Neurological disorders and treatments
- Functional Brain Connectivity Studies
- Pharmacological Effects and Toxicity Studies
- Olfactory and Sensory Function Studies
- Muscle activation and electromyography studies
- Mental Health Research Topics
- Mental Health and Psychiatry
- Obsessive-Compulsive Spectrum Disorders
- Sleep and Wakefulness Research
- Circadian rhythm and melatonin
- Diet and metabolism studies
- Neural dynamics and brain function
- Sleep and related disorders
- Motor Control and Adaptation
- Vestibular and auditory disorders
- Parkinson's Disease Mechanisms and Treatments
- Advanced Chemical Sensor Technologies
- Health Systems, Economic Evaluations, Quality of Life
Fujita Health University
2018-2025
Fujita Health University Hospital
2018-2024
Nippon Soken (Japan)
2013
Tokyo University of Agriculture and Technology
2013
Tottori University
1994-2008
Institute of Neurological Sciences
1994-2008
National College
2008
Tokyo Institute of Technology
2002
National Institute for Physiological Sciences
1997-2001
Abstract Background Estimating the prevalence of schizophrenia in general population remains a challenge worldwide, as well Japan. Few studies have estimated Japanese and often relied on reports from hospitals self-reported physician diagnoses or typical symptoms. These approaches are likely to underestimate true owing stigma, poor insight, lack access health care among respondents. To address these issues, we previously developed an artificial neural network (ANN)–based classification model...
Abstract Background With 30%–50% of people with bipolar depression (BDep) not responding to multiple pharmacological treatments, alternative therapies are needed. Accelerated intermittent theta burst stimulation (aiTBS) over the left dorsolateral prefrontal cortex (L‐DLPFC) has been employed for individuals treatment‐resistant major depressive disorder (TR‐MDD). Imaging studies have revealed reduced regional activity L‐DLPFC both TR‐MDD and BDep (TR‐BDep), suggesting that aiTBS may be...